CD8A and lung cancer: A study found that docetaxel induced CD8+ T cell recruitment into the tumor microenvironment by enhancing the secretion of CXCL11, thus improving antitumor efficacy, and that increased CXCL11 expression was positively correlated with prolonged OS in lung cancer patients.